Capricor Therapeutics
CAPR
#8024
Rank
S$0.37 B
Marketcap
S$8.10
Share price
-4.36%
Change (1 day)
-58.10%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: S$0.37 Billion

As of February 2026 Capricor Therapeutics has a market cap of S$0.37 Billion. This makes Capricor Therapeutics the world's 8024th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.37 B-0.84%
2025S$0.37 B-57.1%
2024S$0.87 B337.59%
2023S$0.19 B52.25%
2022S$0.13 B36.55%
2021S$95.65 M3.1%
2020S$92.78 M928.56%
2019S$9.02 M-48.69%
2018S$17.58 M-67.64%
2017S$54.33 M-34.05%
2016S$82.38 M16.57%
2015S$70.67 M21.83%
2014S$58 M20.53%
2013S$48.12 M1776.59%
2012S$2.56 M-90.85%
2011S$28.02 M1.34%
2010S$27.65 M-39.89%
2009S$46.01 M56.74%
2008S$29.35 M-84.61%
2007S$0.19 B4018.78%
2006S$4.63 M-43.33%
2005S$8.17 M2.06%
2004S$8 M22.38%
2003S$6.54 M-64.33%
2002S$18.34 M

End of Day market cap according to different sources

On Feb 5th, 2026 the market cap of Capricor Therapeutics was reported to be:

S$1.51 Billion
by Nasdaq info icon info icon
S$0.37 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$729.39 B 196,931.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$17.50 B 4,629.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
S$9.37 B 2,433.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$1.91 B 416.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S$34.79 M-90.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
S$6.79 M-98.16%๐Ÿ‡บ๐Ÿ‡ธ USA